The Response Study

Study Objective:

• The study drug is a potential new treatment for inflammatory conditions including Chronic Obstructive Pulmonary disease (COPD) and asthma. The study drug is designed to suppress one of the causes of swelling in the airway lining
  which therefore could potentially decrease the symptoms experienced by people with COPD and asthma

Importance of Treatment:

• COPD and asthma are diseases that cause airflow blockage and breathing-related problems. With COPD and asthma, lungs don't always work the way they should. The airways become damaged because of swelling in airway lining.
• Developing treatments that can prevent the body's immune system from attacking itself (one way or another) is crucial for improving the lives of millions affected globally.

Clinical Trial Details:

• An independent ethics committee has approved this clinical trial.
• Participants will be reimbursed for their time
  

Call us on 1800 243 733 to discuss your eligibility today!